PharmaENG Consultants ApS — Credit Rating and Financial Key Figures
CVR number: 44738104
Byhøjen 5, 2720 Vanløse
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 1 079.94 |
| Employee benefit expenses | - 388.99 |
| EBIT | 690.95 |
| Other financial expenses | -16.43 |
| Pre-tax profit | 674.52 |
| Income taxes | - 151.14 |
| Net earnings | 523.38 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 322.30 |
| Short term receivables total | 322.30 |
| Cash and bank deposits | 533.12 |
| Cash and cash equivalents | 533.12 |
| Balance sheet total (assets) | 855.42 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Shares repurchased | 400.00 |
| Retained earnings | - 400.00 |
| Profit of the financial year | 523.38 |
| Shareholders equity total | 563.38 |
| Non-current liabilities total | |
| Short-term deferred tax liabilities | 163.68 |
| Other non-interest bearing current liabilities | 128.35 |
| Current liabilities total | 292.04 |
| Balance sheet total (liabilities) | 855.42 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.